Last Updated on June 22, 2023

European Journal of Cancer, Supplement- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Elsevier Ltd.

Abbreviation: Eur. J. Cancer Suppl.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.93

SJR

 0.571

h-Index

 28

Rank

 9063

Important Details

Title European Journal of Cancer, Supplement
Standard Abbreviation Eur. J. Cancer Suppl.
Type of Publication Journal
Discipline Cancer Research (Q3); Oncology (Q3)
Impact Score 1.93
SCImago Journal Rank (SJR) 0.571
h-index 28
Overall Rank 9063
Publisher Name Elsevier Ltd.
Publication Country United Kingdom
International Standard Serial Number (ISSN) 13596349
Coverage and History 2003-2016, 2020-2021
Best Quartile Q3
Total Citations Received
(Last 3 Year)
27

About European Journal of Cancer, Supplement


European Journal of Cancer, Supplement is a journal published by Elsevier Ltd.. This journal covers the area[s] related to Cancer Research, Oncology, etc. The coverage history of this journal is as follows: 2003-2016, 2020-2021. The rank of this journal is 9063. This journal's impact score, h-index, and SJR are 1.93, 28, and 0.571, respectively. The ISSN of this journal is/are as follows: 13596349.

The best quartile of European Journal of Cancer, Supplement is Q3. This journal has received a total of 27 citations during the last three years (Preceding 2022).


European Journal of Cancer, Supplement Impact Score 2022-2023


The latest impact score (IS) of the European Journal of Cancer, Supplement is 1.93. It is computed in the year 2023 as per its definition and based on Scopus data. 1.93

It is increased by a factor of around 0.57, and the percentage change is 41.91% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of European Journal of Cancer, Supplement Impact Score 2023


Impact Score 2022 of European Journal of Cancer, Supplement is 1.93. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of European Journal of Cancer, Supplement. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.93
2021 1.36
2020 0.00
2019 0.00
2018 9.00
2017 0.30
2016 2.38
2015 0.53
2014 0.19

European Journal of Cancer, Supplement h-index


  Table Setting

The h-index of European Journal of Cancer, Supplement is 28. By definition of the h-index, this journal has at least 28 published articles with more than 28 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




European Journal of Cancer, Supplement ISSN


The International Standard Serial Number (ISSN) of European Journal of Cancer, Supplement is/are as follows: 13596349.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

European Journal of Cancer, Supplement Ranking and SCImago Journal Rank (SJR)


The European Journal of Cancer, Supplement is ranked 9063 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.571.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


European Journal of Cancer, Supplement Publisher


Table Setting

The publisher of European Journal of Cancer, Supplement is Elsevier Ltd.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2003-2016, 2020-2021.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of European Journal of Cancer, Supplement is Eur. J. Cancer Suppl.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Eur. J. Cancer Suppl.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in European Journal of Cancer, Supplement


If your area of research or discipline is related to Cancer Research, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of European Journal of Cancer, Supplement?

The latest impact score of European Journal of Cancer, Supplement is 1.93. It is computed in the year 2023.


What is the h-index of European Journal of Cancer, Supplement?

The latest h-index of European Journal of Cancer, Supplement is 28. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of European Journal of Cancer, Supplement?

The latest SCImago Journal Rank (SJR) of European Journal of Cancer, Supplement is 0.571. It is calculated in the year 2023.


What is the ranking of European Journal of Cancer, Supplement?

The latest ranking of European Journal of Cancer, Supplement is 9063. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of European Journal of Cancer, Supplement?

European Journal of Cancer, Supplement is published by Elsevier Ltd.. The publication country of this journal is United Kingdom.


What is the abbreviation of European Journal of Cancer, Supplement?

This standard abbreviation of European Journal of Cancer, Supplement is Eur. J. Cancer Suppl..


Is "European Journal of Cancer, Supplement" a Journal, Conference or Book Series?

European Journal of Cancer, Supplement is a journal published by Elsevier Ltd..


What is the scope of European Journal of Cancer, Supplement?

The scope of European Journal of Cancer, Supplement is as follows:

  • Cancer Research
  • Oncology

For detailed scope of European Journal of Cancer, Supplement, check the official website of this journal.


What is the ISSN of European Journal of Cancer, Supplement?

The International Standard Serial Number (ISSN) of European Journal of Cancer, Supplement is/are as follows: 13596349.


What is the best quartile for European Journal of Cancer, Supplement?

The best quartile for European Journal of Cancer, Supplement is Q3.


What is the coverage history of European Journal of Cancer, Supplement?

The coverage history of European Journal of Cancer, Supplement is as follows 2003-2016, 2020-2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
CESifo Economic Studies Journal Oxford University Press 14012 32 1.70
Business Strategy Review Journal Wiley-Blackwell Publishing Ltd 31512 33 0.04
Modern Language Journal Journal Wiley-Blackwell 918 103 3.89
Howard Journal of Communications Journal Taylor and Francis Ltd. 9564 36 1.66
Museum Management and Curatorship Journal Routledge 8168 37 2.65
Journal des Professionnels de l'Enfance Journal TPMA 27577 2 0.00
Proceedings of the Royal Society of Queensland Journal Royal Society of Queensland 22998 12 0.48
Consulting engineer Barrington Journal Cahners Pub. Co. 24079 0 0.00
Integrative Psychological and Behavioral Science Journal Springer New York 14074 39 1.15

Check complete list




European Journal of Cancer, Supplement Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.93
2021 1.36
2020 0.00
2019 0.00
2018 9.00
2017 0.30
2016 2.38
2015 0.53
2014 0.19



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All